Literature DB >> 16699039

Varicella-zoster virus infection of human foreskin fibroblast cells results in atypical cyclin expression and cyclin-dependent kinase activity.

Stacey A Leisenfelder1, Jennifer F Moffat.   

Abstract

In its course of human infection, varicella-zoster virus (VZV) infects rarely dividing cells such as dermal fibroblasts, differentiated keratinocytes, mature T cells, and neurons, none of which are actively synthesizing DNA; however, VZV is able to productively infect them and use their machinery to replicate the viral genome. We hypothesized that VZV alters the intracellular environment to favor viral replication by dysregulating cell cycle proteins and kinases. Cyclin-dependent kinases (CDKs) and cyclins displayed a highly unusual profile in VZV-infected confluent fibroblasts: total amounts of CDK1, CDK2, cyclin B1, cyclin D3, and cyclin A protein increased, and kinase activities of CDK2, CDK4, and cyclin B1 were strongly and simultaneously induced. Cyclins B1 and D3 increased as early as 24 h after infection, concurrent with VZV protein synthesis. Confocal microscopy indicated that cyclin D3 overexpression was limited to areas of IE62 production, whereas cyclin B1 expression was irregular across the VZV plaque. Downstream substrates of CDKs, including pRb, p107, and GM130, did not show phosphorylation by immunoblotting, and p21 and p27 protein levels were increased following infection. Finally, although the complement of cyclin expression and high CDK activity indicated a progression through the S and G(2) phases of the cell cycle, DNA staining and flow cytometry indicated a possible G(1)/S blockade in infected cells. These data support earlier studies showing that pharmacological CDK inhibitors can inhibit VZV replication in cultured cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699039      PMCID: PMC1472175          DOI: 10.1128/JVI.00163-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Cip/Kip proteins: more than just CDKs inhibitors.

Authors:  Catherine Denicourt; Steven F Dowdy
Journal:  Genes Dev       Date:  2004-04-15       Impact factor: 11.361

Review 2.  Assembly-disassembly of the nuclear lamina.

Authors:  E A Nigg
Journal:  Curr Opin Cell Biol       Date:  1992-02       Impact factor: 8.382

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Herpes simplex virus type 1 infection induces activation and recruitment of protein kinase C to the nuclear membrane and increased phosphorylation of lamin B.

Authors:  Richard Park; Joel D Baines
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  Phosphorylation of varicella-zoster virus glycoprotein gpI by mammalian casein kinase II and casein kinase I.

Authors:  C Grose; W Jackson; J A Traugh
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

6.  Role for Cdk1 (Cdc2)/cyclin A in preventing the mammalian origin recognition complex's largest subunit (Orc1) from binding to chromatin during mitosis.

Authors:  Cong-jun Li; Alex Vassilev; Melvin L DePamphilis
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

7.  Roscovitine, a cyclin-dependent kinase inhibitor, prevents replication of varicella-zoster virus.

Authors:  Shannon L Taylor; Paul R Kinchington; Andrew Brooks; Jennifer F Moffat
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

8.  Identification of target genes of the p16INK4A-pRB-E2F pathway.

Authors:  Richard Vernell; Kristian Helin; Heiko Müller
Journal:  J Biol Chem       Date:  2003-08-15       Impact factor: 5.157

Review 9.  Viral and cellular kinases are potential antiviral targets and have a central role in varicella zoster virus pathogenesis.

Authors:  Jennifer F Moffat; Michelle A McMichael; Stacey A Leisenfelder; Shannon L Taylor
Journal:  Biochim Biophys Acta       Date:  2004-03-11

10.  A complex containing p34cdc2 and cyclin B phosphorylates the nuclear lamin and disassembles nuclei of clam oocytes in vitro.

Authors:  G Dessev; C Iovcheva-Dessev; J R Bischoff; D Beach; R Goldman
Journal:  J Cell Biol       Date:  1991-02       Impact factor: 10.539

View more
  15 in total

Review 1.  Epidemiologic perspective on immune-surveillance in cancer.

Authors:  Daniel W Cramer; Olivera J Finn
Journal:  Curr Opin Immunol       Date:  2011-02-01       Impact factor: 7.486

2.  Healthy individuals have T-cell and antibody responses to the tumor antigen cyclin B1 that when elicited in mice protect from cancer.

Authors:  Laura A Vella; Min Yu; Steven R Fuhrmann; Moustapha El-Amine; Diane E Epperson; Olivera J Finn
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-03       Impact factor: 11.205

Review 3.  Human Tumor Antigens Yesterday, Today, and Tomorrow.

Authors:  Olivera J Finn
Journal:  Cancer Immunol Res       Date:  2017-05       Impact factor: 11.151

4.  Compounds that target host cell proteins prevent varicella-zoster virus replication in culture, ex vivo, and in SCID-Hu mice.

Authors:  Jenny Rowe; Rebecca J Greenblatt; Dongmei Liu; Jennifer F Moffat
Journal:  Antiviral Res       Date:  2010-03-20       Impact factor: 5.970

5.  Influenza virus infection elicits protective antibodies and T cells specific for host cell antigens also expressed as tumor-associated antigens: a new view of cancer immunosurveillance.

Authors:  Uzoma K Iheagwara; Pamela L Beatty; Phu T Van; Ted M Ross; Jonathan S Minden; Olivera J Finn
Journal:  Cancer Immunol Res       Date:  2013-12-05       Impact factor: 11.151

6.  Varicella-zoster virus infection of human fibroblast cells activates the c-Jun N-terminal kinase pathway.

Authors:  Heidi J Zapata; Masako Nakatsugawa; Jennifer F Moffat
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

Review 7.  Vaccines for cancer prevention: a practical and feasible approach to the cancer epidemic.

Authors:  Olivera J Finn
Journal:  Cancer Immunol Res       Date:  2014-08       Impact factor: 11.151

8.  The phosphorylation profile of protein kinase A substrates is modulated during Varicella-zoster virus infection.

Authors:  Nathalie Desloges; Markus Rahaus; Manfred H Wolff
Journal:  Med Microbiol Immunol       Date:  2007-12-08       Impact factor: 3.402

9.  Cyclin-dependent kinase 1/cyclin B1 phosphorylates varicella-zoster virus IE62 and is incorporated into virions.

Authors:  Stacey A Leisenfelder; Paul R Kinchington; Jennifer F Moffat
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

Review 10.  Personal history of infections and immunotherapy: Unexpected links and possible therapeutic opportunities.

Authors:  Camille Jacqueline; Nathalie Bonnefoy; Guillaume M Charrière; Frédéric Thomas; Benjamin Roche
Journal:  Oncoimmunology       Date:  2018-06-11       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.